Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0VE0F
|
||||
| Former ID |
DNC006243
|
||||
| Drug Name |
(S)-1-benzylcyclopentyl 1-oxohexan-2-ylcarbamate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527872] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H27NO3
|
||||
| Canonical SMILES |
CCCCC(C=O)NC(=O)OC1(CCCC1)CC2=CC=CC=C2
|
||||
| InChI |
1S/C19H27NO3/c1-2-3-11-17(15-21)20-18(22)23-19(12-7-8-13-19)14-16-9-5-4-6-10-16/h4-6,9-10,15,17H,2-3,7-8,11-14H2,1H3,(H,20,22)/t17-/m0/s1
|
||||
| InChIKey |
ONABDOMWRCXLPX-KRWDZBQOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin B | Target Info | Inhibitor | [527872] | |
| Cathepsin L | Target Info | Inhibitor | [527872] | ||
| Cathepsin K | Target Info | Inhibitor | [527872] | ||
| Reactome | Collagen degradation | ||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Degradation of the extracellular matrix | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| Activation of Matrix Metalloproteinases | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.